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Abstract
Background: Schistosomes are parasitic helminths that infect humans through dermo-invasion while in
contaminated water. Salmonella are also a common water-borne human pathogen that infects the gastrointestinal
tract via the oral route. Both pathogens eventually enter the systemic circulation as part of their respective disease
processes. Concurrent Schistosoma-Salmonella infections are common and are complicated by the bacteria
adhering to adult schistosomes present in the mesenteric vasculature. This interaction provides a refuge in which
the bacterium can putatively evade antibiotic therapy and anthelmintic monotherapy can lead to a massive release
of occult Salmonella.
Results: Using a novel antibiotic protection assay, our results reveal that Schistosoma-associated Salmonella are
refractory to eight different antibiotics commonly used to treat salmonellosis. The efficacy of these antibiotics was
decreased by a factor of 4 to 16 due to this association. Salmonella binding to schistosomes occurs via a specific
fimbrial protein (FimH) present on the surface on the bacterium. This same fimbrial protein confers the ability of
Salmonella to bind to mammalian cells.
Conclusions: Salmonella can evade certain antibiotics by binding to Schistosoma. As a result, effective bactericidal
concentrations of antibiotics are unfortunately above the achievable therapeutic levels of the drugs in co-infected
individuals. Salmonella-Schistosoma binding is analogous to the adherence of Salmonella to cells lining the
mammalian intestine. Perturbing this binding is the key to eliminating Salmonella that complicate schistosomiasis.
Background
Schistosomes are parasitic helminths that infect humans,
with life cycles involving snails as intermediate hosts.
Schistosomiasis occurs in 74 developing tropical and
subtropical countries in which over 200 million people
are infected. Of those, 120 million patients show symp-
toms with 20 million severely infected. There are 14,000
deaths per year due to schistosomiasis [1].
Salmonella spp. is a common water- and food-borne
cause of gastrointestinal and systemic diseases world-
wide. Approximately 2 million individuals die each year
from diarrheal disease and Salmonella is a leading cause
of this malady. In the U.S. alone, Salmonella causes
about 1.4 million infections per year [2].
Concurrent Schistosoma-Salmonella infections occur
when enteroinvasive Salmonella enter the systemic cir-
culation and attach to the tegument of adult Schisto-
soma [3,4] present in the mesenteric vasculature. This
interaction apparently provides a refuge in which the
bacterium can evade systemic antibiotic therapy. For
example, chloramphenicol-sensitive S. typhi were
demonstrated to be refractory to chloramphenicol treat-
ment in co-infections [5]. Furthermore, therapy with the
anthelmintic praziquantel can lead to a massive release
of schistosome-associated Salmonella causing peracute
septicemia if the appropriate antibiotic is not co-admi-
nistered to co-infected children [6,7]. Finally, the use of
ineffective antibiotics contributes to antibiotic resistance
development and the phenomenon of bacterial
persistence.
To assess the nature and extent of this phenomenon,
we developed an in vitro antibiotic protection assay in
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using various Salmonella incubated with adult schisto-
somes and a variety of antibiotics. These studies identify
Salmonella factors that facilitate attachment to Schisto-
soma while also cataloguing the antibiotics that are inef-
fective against Salmonella adhering to schistosomes.
Results
Assessment of qualitative amoxicillin resistance in
Salmonella adhering to schistosomes
To determine if Salmonella can evade the effects of
antibiotics through adherence to schistosomes, we
developed a novel antibiotic protection assay in which
antibiotic-sensitive Salmonella typhimurium (strains
listed in Table 1) were incubated with a therapeutically-
relevant concentration of amoxicillin (32 μg/ml) known
to be 100% lethal to these strains in the absence of
schistosomes [2]. Salmonella typhimurium strains
included SL1344 (invasive), BJ68 (non-invasive), and
EE419 (hyperinvasive). As part of the control conditions,
bacterial killing was determined prior to co-incubation
with schistosomes and following adherence to schisto-
somes. Additional controls included assessing amoxicil-
lin-mediated killing of Salmonella adhering to Girardia
tigrina (free-living flatworms) and to HEp-2 mammalian
tissue culture cells. A laboratory strain of E. coli
(Top10) was also used as a control.
As shown in Figure 1, bacterial survival was signifi-
cantly higher (p <0.01) during adherence to schisto-
somes when compared to the other conditions for
Salmonella. Specifically, whereas 32 μg/ml amoxicillin
kills essentially 100% of the Salmonella strains incubated
alone, it kills less than 12% of the same strains incu-
bated with adult schistosomes. This schistosome protec-
tive effect was not dependent upon the ability of
Salmonella to invade the eukaryotic cells since the non-
invasive strain was protected from amoxicillin in a man-
ner similar to that observed for invasive and hyperinva-
sive strains. The protective effect could not be replicated
by co-incubation with the free-living flatworm G. tigrina
or with HEp-2 mammalian tissue culture cells. Further,
S. mansoni afforded no protection to E. coli.
Quantitative evaluation of amoxicillin resistance in
Salmonella adhering to schistosomes
To assess the concentration-dependent nature of schis-
tosome-mediated Salmonella resistance to antibiotic kill-
ing, we used the antibiotic protection assay to obtain
amoxicillin kill curves for Salmonella adhering to schis-
tosomes. Salmonella and Schistosoma were co-incubated
in the presence of various concentrations of amoxicillin.
Control conditions include determining bacterial killing
in the presence of HEp-2 mammalian tissue culture
cells.
For most concentrations of amoxicillin, bacterial survi-
val was significantly higher (p <0.01) during adherence
to schistosomes when compared to HEp-2 cells adher-
ence (Figure 2). The apparent minimum inhibitory con-
centration (MIC), i.e. the lowest concentrations that kills
or inhibits the growth of 100% of Salmonella in an in
vitro inoculum containing 10
6 bacteria/ml, was 16 μg/ml
in the presence of HEp-2 cells but 16 times higher for
Salmonella adhering to Schistosoma.
Evaluation of Schistosoma-mediated protection of
Salmonella from other antibiotics
To determine if Salmonella can evade the effects of
antibiotics other than amoxicillin, studies presented in
Figure 1 were repeated using the invasive strain of Sal-
monella (SL1344) and clinically-relevant concentrations
of seven other antibiotics. Other antibiotics included
cefepime, cefpodoxime, chloramphenicol, ciprofloxacin,
Table 1 Summary of bacteria used in this study
Bacterium Relevant Characteristics Reference
Salmonella typhimurium strain
SL1344
Invasive; adherent to mammalian cells [12]
Salmonella typhimurium strain BJ68 Non-invasive; adherent to mammalian cells [13]
Salmonella typhimurium strain EE419 Hyperinvasive; adherent to mammalian cells [14]
Salmonella paratyphi Adapted to humans; adherent to mammalian cells [9]
Salmonella pullorum/gallinarum Adherent to avian cells [8]
Salmonella pullorum/pFimH Engineered to be adherent to mammalian cells via heterologous expression of FimH from
SL1344
This study
Salmonella typhimurium/dFimH Engineered to be non-adherent to mammalian cells via transposon-mediated deletion of fimH This study
Salmonella javiana Adherent to mammalian and reptilian cells [15]
Shigella flexneri Human pathogen related to Salmonella [19]
E. coli Top10 Non-invasive and non-adherent
E. coli (ETEC, EPEC, and EHEC) Invasive and adherent
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Page 2 of 8streptomycin, sulfadimethoxine, or tetracycline. Cefe-
pime (4
th generation cephalosporin), cefpodoxime (3
rd
generation cephalosporin), and ciprofloxacin (fluoroqui-
nolone) represent the antibiotics currently recom-
mended for use against systemic salmonellosis [2].
Chloramphenicol was chosen because of documented
treatment failures in Salmonella-Schistosoma co-infec-
tions despite chloramphenicol sensitivity exhibited by
the Salmonella isolate [5]. Streptomycin, sulfadimethox-
ine, and tetracycline are other antibiotics that have been
previously used to treat systemic salmonellosis [2].
As shown in Figure 3, bacterial survival was signifi-
cantly higher (p <0.01) during adherence to schisto-
somes when compared to the other conditions for all
antibiotics. Table 2 illustrates the quantitative nature of
t h er e s i s t a n c ew h e r ea d h e r e n c et oSchistosoma
significantly increased the apparent MIC values beyond
the clinical breakpoint, i.e. MIC value that is ascribed as
the threshold for sensitivity/resistance, for each antibio-
tic. Again, this protection was not provided by co-incu-
bation with either G. tigrina or mammalian cells, where
in every instance killing was not significantly lower than
100%. Also, this protection was not afforded to E. coli
incubated with schistosomes.
Assessment of FimH as a determinant of Salmonella
adherence to Schistosoma
Previous studies indicated that Salmonella fimbrial pro-
teins participate in the binding to Schistosoma [3,4]. Fim-
brial proteins, specifically FimH, confer selective binding
properties to mammalian versus avian hosts. The T78⇒I
mutation in FimH confers avian cell binding to Salmonella
Figure 1 Amoxicillin resistance in Salmonella adhering to schistosomes (black boxes). Approximately 10
4 CFUs of antibiotic-sensitive
Salmonella typhimurium were incubated with a single adult Schistosoma for two hours followed by the addition of the “breakpoint”
concentration [16] of amoxicillin (32 μg/ml). Following washing of the antibiotic, Salmonella were liberated from eukaryotes by trypsinization and
bacteria were then recovered and enumerated for determination of percent bacterial killing. Salmonella typhimurium strains include SL1344
(invasive), BJ68 (non-invasive), and EE419 (hyperinvasive). Control conditions include determining bacterial killing prior to co-incubation with
schistosomes (open boxes) and following adherence to schistosomes (vertical hatching). Additional controls included the assessment of
antibiotic-mediated killing of Salmonella adhering to Girardia free-living flatworms (horizontal hatching) and HEp-2 mammalian tissue culture
cells (gray boxes). A laboratory strain of E. coli (Top10) was also used as a control. Data presented are the mean ± SEM for three independent
experiments each performed in triplicate. *, bacterial survival was significantly higher (p <0.01) during adherence to schistosomes when
compared to the other conditions for Salmonella.
Barnhill et al. Parasites & Vectors 2011, 4:123
http://www.parasitesandvectors.com/content/4/1/123
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FimH confers mammalian cell binding to many Salmo-
nella including S. typhimurium and the human-adapted S.
paratyphi. Therefore, this mutation may play a role in Sal-
monella-Schistosoma adherence. In the present study,
schistosome-mediated protection from antibiotics was
evaluated in Salmonella expressing mammalian cell-bind-
ing FimH (threonine at amino acid 78) or avian cell-bind-
ing FimH (isoleucine at amino acid 78).
As shown in Figure 4, protection from antibiotics was
only afforded to Salmonella expressing mammalian cell-
binding FimH. Deletion of FimH abrogated the schisto-
some-mediated protection for Salmonella typhimurium.
Further, Salmonella pullorum, which was not protected
by co-incubation with schistosomes, became protected
with the heterologous expression of the mammalian
cell-binding FimH. Table 3 summarizes the relationship
between expression of mammalian cell binding FimH
and the antibiotic protection afforded by schistosomes.
Discussion
A previous study documents antibacterial treatment fail-
ures in Schistosoma-Salmonella co-infections despite in
vitro sensitivity to the drug in the absence of schisto-
somes [5]. Other studies revealed that Salmonella can
adhere to the tegument of Schistosoma and that this
adherence is dependent upon fimbriae present on the
surface of Salmonella [3,4]. The study herein describes
experiments addressing the hypothesis that Schistosoma-
associated Salmonella can evade a number of antibiotics
by binding to adult schistosomes using fimbrial proteins
implicated in mammalian cell adherence.
Antibiotic protection studies revealed that eight differ-
ent anti-Salmonella antibiotics were incapable of effec-
tively killing or inhibiting the bacterium when adhered
to Schistosoma, despite efficacy of these drugs against
Salmonella that were not associated with schistosomes.
This effect was not related to Salmonella invading the
tegumental cells of schistosomes since a non-invasive
isostrain was recalcitrant to the antibiotics and a hyper-
invasive isostrain did not exhibit any significant eleva-
tion of antibiotic resistance. This phenomenon was not
observed for Salmonella binding to other eukaryotic
cells such as HEp-2 mammalian epithelial cells or tegu-
mental cells on the surface of the free-living flatworm
G. tigrina. Bacterial growth was minimal and equivalent
*
g
*
Figure 2 Kill-curve obtained for Salmonella incubated with Schistosoma or HEp-2 cells in the presence of various concentrations of
amoxicillin. Approximately 10
4 CFUs of antibiotic-sensitive Salmonella typhimurium were incubated with a single adult Schistosoma or HEp-2
cells for two hours followed by the addition of various concentrations of amoxicillin. Data presented are the percentages of Salmonella killed by
amoxicillin during attachment to schistosomes (black circles) or HEp-2 cells (red boxes). The native breakpoint for amoxicillin (32 μg/ml [17]) is
indicated by the vertical dashed green line. Data presented are the mean ± SEM for three independent experiments each performed in
triplicate. *p <0.01 versus HEp-2 controls for 0.5-128 μg/ml of amoxicillin. Similar results were observed for other antibiotics (summarized in
Table 2).
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Page 4 of 8Figure 3 Schistosoma-mediated protection of Salmonella exposed to amoxicillin, cefepime, cefpodoxime, chloramphenicol,
ciprofloxacin, streptomycin, sulfadimethoxine, or tetracycline. Approximately 10
4 CFUs of antibiotic-sensitive Salmonella typhimurium were
incubated with a single adult Schistosoma for two hours followed by the addition of the “breakpoint” concentration [17] of an antibiotic. Data
presented are the percentages of Salmonella killed or inhibited by antibiotics prior to incubation with schistosomes (open boxes) or in the
presence of Schistosoma (black boxes). Data presented are the mean ± SEM for three independent experiments each performed in triplicate.
Bacterial survival was significantly higher (p <0.01) during adherence to schistosomes when compared to the schistosome-free condition for a
given antibiotic. No significant differences were noted for survival of bacteria prior to schistosome attachment, following attachment to
schistosomes, in the presence of HEp-2 cells, or in the presence of Girardia (data not shown).
Table 2 Apparent MIC data for Salmonella adhering to Schistosoma
Antibiotic MICs and Breakpoints
MIC prior to exposure to
Schistosoma
MIC during adherence to
Schistosoma
MIC following exposure to
Schistosoma
Breakpoint of the antibiotic for
Salmonella [17]
amoxicillin 16 μg/ml 256 μg/ml 16 μg/ml 32 μg/ml
cefepime 16 μg/ml 128 μg/ml 16 μg/ml 32 μg/ml
cefpodoxime 32 μg/ml 256 μg/ml 32 μg/ml 32 μg/ml
chloramphenicol 16 μg/ml 64 μg/ml 16 μg/ml 32 μg/ml
ciprofloxacin 0.25 μg/ml 8 μg/ml 0.25 μg/ml 4 μg/ml
streptomycin 16 μg/ml 256 μg/ml 16 μg/ml 32 μg/ml
sulfadimethoxine 128 μg/ml 1024 μg/ml 64 μg/ml 512 μg/ml
tetracycline 8 μg/ml 64 μg/ml 8 μg/ml 16 μg/ml
Italicized number indicate resistance to the respective antibiotic. Adherence to HEp-2 cells or Girardia had no effect on the apparent MIC values for Salmonella
(not shown). Adherence to schistosomes had no effect on the apparent MIC values for pathogenic and avirulent E. coli (not shown).
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when incubated with only RPMI media (data not
shown).
The binding of Salmonella to Schistosoma is depen-
dent upon a specific fimbrial protein expressed by
Salmonella that attach to mammalian cells. Various Sal-
monella serotypes have specific host tropisms and fim-
brial proteins dictate this host range phenomenon [8].
Salmonella pullorum and Salmonella gallinarum are
avian-adapted Salmonella and schistosomes protected
Figure 4 Amoxicillin killing of various Salmonella strains adhering to schistosomes. Salmonella and Schistosoma were co-incubated,
exposed to 32 μg/ml of amoxicillin, recovered and enumerated as described above. Data presented are the percentages of Salmonella killed or
inhibited by antibiotics prior to incubation with schistosomes (open boxes) or in the presence of Schistosoma (black boxes). Bacterial survival was
significantly higher (p <0.01) during adherence to schistosomes for Salmonella expressing the FimH that confers mammalian cell adherence. No
significant differences were noted for survival of bacteria prior to schistosome attachment, following attachment to schistosomes, in the
presence of HEp-2 cells, or in the presence of Girardia (data not shown).
Table 3 Summary of antibiotic resistance in bacteria associated with Schistosoma
Bacteria (all natively sensitive to antibiotics) Relevant Characteristics Resistant or Sensitive
Salmonella typhimurium;
Salmonella paratyphi;
Salmonella pullorum/pFimH;
Salmonella javiana
Express a FimH protein with Thr at amino acid 78 Resistant
Salmonella typhimurium/dFimH;
Salmonella pullorum;
Salmonella gallinarum
Express a FimH protein with Ile at amino acid 78 Sensitive
Shigella flexneri;
E. coli
Invade and attach via alternative processes Sensitive
Resistance/sensitivity determinations are based on apparent MIC values exceeding the breakpoint for each of the eight antibiotics examined.
Barnhill et al. Parasites & Vectors 2011, 4:123
http://www.parasitesandvectors.com/content/4/1/123
Page 6 of 8neither of these serotypes whereas broad host range ser-
otypes, like S. typhimurium and S. javiana,w e r ep r o -
tected from the antibiotics. Mammalian-adapted
Salmonella paratyphi, which is adapted to humans [9],
is refractory to the antibiotics upon association with
Schistosoma. FimH is a fimbrial protein that endows
selective eukaryotic cell adherence [8] and our studies
revealed that schistosomal adherence is absent for Sal-
monella that express the avian cell-specific version of
this fimbria. It would therefore appear that Schistosoma
bear a cell surface epitope that is analogous to the
mammalian cell-docking site for FimH.
Since the antibiotic resistance is transient and only
occurs during adherence, the mechanism for the resis-
tance is likely a physical barrier that may include a bio-
film. The glycocalyx of Schistosoma is thick, highly
immunogenic, and fucose-rich [10] suggesting that anti-
biotics may poorly penetrate this milieu. Given the che-
mical diversity of the antibiotics used in this study, it is
unlikely that the schistosome glycocalyx is capable of
chemically altering and inactivating the drugs. Bacterial
quiescence is another possibility but Salmonella depend
on folate auto-deprivation and the temporal nature of
this phenomenon [11] is not likely to occur during the
protection assay. The same can be said for the activation
of other metabolic changes in Salmonella physiology, i.
e., the two hour incubation period is likely insufficient
for inducing resistance. Further studies will address the
physical basis for the phenomenon described herein.
Conclusions
Schistosoma-associated Salmonella can evade certain
antibiotics during adherence to the flatworm. As a result,
traditional anti-Salmonella drugs are not useful in co-
infected individuals. Bacteria-flatworm binding mimics
the adherence of Salmonella to cells lining the mamma-
lian intestine. Perturbing this binding is the key to elimi-
nating Salmonella that complicate schistosomiasis.
Methods
Summary of microbes used in this study
Bacterial strains are summarized in Table 1 with Salmo-
nella typhimurium strain SL1344 [12] serving as the
model invasive strain. Non-invasive isostrain BJ68 [13]
and hyperinvasive strain EE419 [14] are both derivatives
of SL1344. Other Salmonella include human-adapted S.
paratyphi [9] and the broad host-range S. javiana that
infects mammals and reptiles [15]. Avian-adapted S.
pullorum was also used in these studies. Bacteria were
stored in cryopreservation tubes containing 50% gly-
cerol:50% culturem e d i u ma t- 8 0 ° Ca n dg r o w ni nL B
broth (Sigma) without antibiotics.
To assess the role of specific fimbriae in the adherence
of Salmonella to schistosomes, the fimH gene was PCR-
amplified from SL1344 and cloned into the prokaryotic
expression vector pCR2.1 (Invitrogen). This plasmid,
designated as pFimH, was transformed into Salmonella
pullorum and the transformant is designated as Salmo-
nella pullorum/pFimH.
Additionally, S. typhimurium was engineered to
express the S. pullorum-specific FimH bearing the
T78⇒I mutation that abrogates adherence to mamma-
lian cells. First, the TnZeo [16] transposon was inserted
into fimH of SL1344 thus preventing expression of
native fimH. Since this deletion will have polar effects
on the polycistronic fim transcript, the fim operon
(fimABCDHFZYW) was PCR-amplified from S. pull-
orum, cloned into the pCRXL prokaryotic expression
vector, and transformed into SL1344 bearing the TnZeo
insertion into fimH.T h i ss t r a i ni sd e s i g n a t e da sSalmo-
nella typhimurium/dFimH.
Non-Salmonella bacteria included pathogenic Shigella,
pathogenic E. coli, and a laboratory strain of E. coli.
These bacteria are related to Salmonella but they
express fimbriae that are divergent from those found in
Salmonella.
Isolation of parasites
Adult male Schistosoma mansoni worms were recovered
45-60 days post-infection from portal and mesenteric
veins of Swiss Webster female mice provided by the
Biomedical Research Institute, Rockville MD, USA. All
animal procedures were conducted in accordance with
Iowa State University’s approved animal care protocol
#07-I-025-A/H.
Antibiotic protection assay
Approximately 10
4 CFUs of antibiotic-sensitive bacteria
were incubated with a single adult Schistosoma in 12-well
tissue culture dishes containing 1 mL of RPMI (Invitro-
gen) with 50% fetal bovine serum (Difco). Co-incubations
lasted for two hours followed by the addition of the
“breakpoint” concentrations [17] of one of the following
antibiotics: amoxicillin (32 μg/ml), cefepime (32 μg/ml),
cefpodoxime (32 μg/ml), chloramphenicol (32 μg/ml),
ciprofloxacin (4 μg/ml), streptomycin (32 μg/ml), sulfadi-
methoxine (512 μg/ml), or tetracycline (16 μg/ml). All
antibiotics were obtained from Sigma Chemicals.
Following washing of the antibiotic after 2 hrs, trypsin
(0.05%) was then added in order to cleave the Salmo-
nella fimbriae that mediate the attachment to Schisto-
soma [3,18]. Media was then removed and plated on
Salmonella-selective agar that was incubated at 37°C
overnight. Salmonella colonies were then enumerated
for determination of percent of bacteria recovered, i.e.
an indirect measurement of bacterial killing. Percent
bacterial killing equals 100 ×(10
4 minus the number of
CFUs recovered)/10
4.
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ing prior to co-incubation with schistosomes, during
adherence to schistosomes, and following adherence to
schistosomes. The latter situation refers to worms that
were removed from the schistosomes and then exam-
ined for antibiotic susceptibilities, a measurement of the
duration (or lack thereof) of the resistance afforded by
schistosomes. Additional controls included the assess-
ment of antibiotic-mediated killing of Salmonella adher-
ing to Girardia free-living flatworms and HEp-2
mammalian tissue culture cells.
Concentration-response analysis of antibiotic resistance
exhibited by Schistosoma-associated Salmonella
typhimurium SL1344
Various concentrations of antibiotics (0-1,024 μg/ml)
were used in the antibiotic protection assay described
above. Percent bacterial killing was determined for
SL1344 adhering to schistosomes, Girardia,o rH E p - 2
cells. As a control, bacterial killing was assessed in
eukaryotic cell-free assays and in the presence of HEp-2
cells. Apparent antibiotic minimum inhibitory concen-
trations (MICs) were ascribed to the lowest concentra-
tion of antibiotic that inhibited or killed 100% of the
bacterial inocula.
Statistics
Statistical analysis was performed using ANOVA with
Scheffe’s F test for multiple comparisons. Comparisons
were made between strains and between incubation
conditions.
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